Reata Pharmaceuticals, Inc. - Class A (RETA) Covered Calls

You can sell covered calls on Reata Pharmaceuticals, Inc. - Class A to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for RETA (prices last updated Fri 4:16 PM ET):

Reata Pharmaceuticals, Inc. - Class A (RETA) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
26.18 -1.08 23.19 29.00 486K - 1.0
Covered Calls For Reata Pharmaceuticals, Inc. - Class A (RETA)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
Feb 18 25 2.95 26.05 -4.0% -50.3%
Mar 18 25 3.80 25.20 -0.8% -5.1%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Reata Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on identifying, developing, and commercializing therapeutics to address serious and life-threatening diseases with therapies by targeting molecular pathways that regulate cellular metabolism and inflammation. The company is developing Phase III clinical trial programs, including bardoxolone methyl for the treatment of patients with chronic kidney disease caused by Alport syndrome; and for a form of pulmonary arterial hypertension associated with connective tissue disease. It is also developing omaveloxolone that is Phase II clinical trial for the treatment of patients with Friedreich's ataxia. The company was formerly known as Reata Discovery, Inc. and changed its name to Reata Pharmaceuticals, Inc. in May 2005. Reata Pharmaceuticals, Inc. was founded in 2002 and is headquartered in Irving, Texas.